Annual Report 2013 of Beximco Pharmaceuticals Limited

It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2013. In 2013, The Company achieved a sales turnover of BDT 10.49 billion with a year-on-year growth of 12.94%. BPL domestic business posted a growth of 11.34% while the industry grew by 8.12%. Net sales revenue in 2013 has grown by 12.94% to reach Taka. 10,490.1 million as against Taka. 9,289.1 million in 2012. During 2013, Profit before tax increased by 9.62% compared to that of last year to reach Taka. 2,093.6 million. Profit after tax also increased by 6.47% to reach Taka. 1,404.8 million. Gross profit declined by 1.13% in 2013. Beximco Pharmaceuticals Ltd. won the prestigious Asia’s Most Promising Brand award at the Asian Brand & Leadership Summit 2013 held during 26-27^th August 2013 in Dubai.

The Board of Directors is pleased to recommend 10% Cash Dividend i.e. Tk. 1 per share and 5% Stock Dividend i.e. 5 shares for every 100 shares held for the year 2013 for onward approval in the Annual General Meeting. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Beximco Pharmaceuticals Limited :